ENTRAR            

 


 

PRESENCIA salud mental, investigacin y humanidades ISSN: 1885-0219

 

 

 ORIGINALES

 

 

 Ir a Sumario

 

 

 

Déficit de Vitamina B12, demencia y Trastorno depresivo en población diabética mayor de 60 años*

Maria Luisa Lozano del Hoyo
E
nfermera, Centro de Salud Las Fuentes Norte. Zaragoza (Aragón), España

Manuscrito recibido el 25.8.16
Manuscrito aceptado el 22.3.17

Rev Presencia 2017; V13
*Este trabajo fue presentado como trabajo fin de Master de Gerontología y como poster en el XXVII Congreso Nacional de la Sociedad Española de Diabetes

 

 

 

Cómo citar este documento

Lozano del Hoyo, Maria Luisa. Déficit de Vitamina B12, demencia y Trastorno depresivo en población diabética mayor de 60 años. Rev Presencia 2017; V13. Disponible en <http://www.index-f.com/p2e/v13/e11069.php> Consultado el

 

Resumen

Objetivo principal: Evaluar el diagnóstico de déficit de vitamina B12, trastorno depresivo y demencia en diabéticos tipo 2 mayores de 60 años. Metodología: Diseño descriptivo trasversal. Resultados principales: Hay un 30'3% de pacientes con diagnóstico de trastorno depresivo, 9'1% con demencia y 7'4% con déficit de vitamina B12. La media de años tomando metformina es de 3,9±4,4, dosis media 1'7± 0'6 mg. El riesgo de déficit de Vitamina B12 se multiplica por 1'8 si es hombre (RR=1'4). Las tres patologías tienen en común más de 4 años de diagnóstico y obesidad. El déficit de vitamina B12 y el Trastorno depresivo coinciden en la edad. No se pide vitamina B12 en el 91'3% de los pacientes. Se definen tres pacientes reto a identificar en consulta de enfermería. Conclusión principal: Hay infra diagnóstico de las tres patologías asociadas.
Palabras clave: Déficit de Vitamina B12/ Trastorno depresivo/ Demencia/ Diabetes mellitus.

 

 

Abstract (Vitamine B12 deficit, dementia and dpresive disorder in diabetic population over 60)

Objective: Evaluaring the diagnosis of vitamin B12 deficit, depressive disorder and dementia in diabetic tipe 2 over 60. Methods: Cross-sectional design. Results: There is 30'3% of patients diagnosed with depressive disorder, 9'1% with dementia and 7'4% with vitamin B12 deficit. The average of the years taking metformine is 3,9±4,4, mean dose 1'7± 0'6 mg. The risk of vitamin B12 deficit is multipled by 1'8 if it is a man (RR=1'4). Those three patologies have in common more tan 4 years of diagnosis and obesity. The vitamin B12 deficit and the depressive disorder mismatch in the age. Vitamin B12 is not ordered in 91'3% of the patients. Three patients defined challenge identified in consultation nursing. Conclusions: There is under diagnosis in those three associated pathologies.
Key-words: Vitamin B12 deficit/ Depressive disorder/ Dementia and diabetes mellitus.

 

Bibliografía

1. International Diabetes Federation. Diabetes Atlas 4th edition. Accessed May 3nd [Internet], 2010 [Citado el 18 de Dic. De 2014]. Disponible desde: http://www.worlddiabetesfoundation.org/composite-35.htm
2. Estrategia de Diabetes del Sistema Nacional de Salud. Sanidad [Internet] 2012. Ministerio de Sanidad, Servicios Sociales e Igualdad [Citado el 10 de Enero de 2015]. Disponible desde:
http://www.observatorio.naos.aesan.msssi.gob.es/docs/documentos/estrategia_en_diabetes
3. Wile D. Association of metformin, elevated homocysteine, and methymalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care. 2010; 33(1):156-61.
4. De Jager J, Kooy A, Lehert P, Wulffelé MG, van del Kol KJ, Bets D et al. Long term treatment with metformin in patients with type 2 diabetes and risk of viramin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010; 340(4):2181-4.
5. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP Jr. Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements: the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 2012; 35(2):327-33.
6. Sánchez H, Masferrer D, Lera L, Arancibia E, Ángel B, Albala C. Déficit de Vitamina B12 asociado con altas dosis de metformina en adultos mayores diabéticos. Nutr Hosp. 2014; 29(6): 1394-400.
7. De Groot-Kamphuis DM, van Dijk PR, Groenier KH, Houwe ling ST, Bilo HJG, Kleefstra N. Vitamin B12 deficiency and the lack of its consequences in type 2 diabetes patients using metformin. Neth J Med. 2013; 71 (7):386-90.
8. Ting RZ-W, Szeto CC, Chan MH-M, Ma KK, Chow KM. Risk factors of vitamin B(12) deficiency in patients receiving metformin. Arch Intern Med. 2006; 166(18):1975-9.
9. American Diabetes Associatión. Standars of medical care in diabetes 2013. Diabetes Care. 2013; 36(1):11-66.
10. Trento M, Raballo M, Trevisan M, Sicuro J, Passera P, Cirio L, et al. A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetol. 2012; 49(3):199-203.
11. Furuya M, Hayashino Y, Tsujii S, Ishii H, Fukuhara S. Comparative validity of the WHO-5 Well-Being Index and two-question instrument for screening depressive symptoms in patients with type 2 diabetes. Acta Diabetol. 2013; 50(2):117-21.
12. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006; 5(1):64-74.
13. Eussen SJ, de Groot LC, Joosten LW, Bloo RJ, Clake R, Ueland PM et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency. Am J Clin Nutr. 2006; 84(2):361-70.
 14. Kibirige D, Mwebaze R. Vitamin B12 deficiency among patients with diabetes mellitus: is routine screening and supplementation justified? Journal of Diabetes & Metabolic Disorders. 2013; 12(3):17-9.
 15. Katon WJ, Lin EH, Von Korff M, Ciechanowski P, Ludman EJ, Yoing B, et all. Collaborative Care for Patients with Depression and Chronic Illnesses. N Engl J Med. 2010; 363:2611-20.
16. Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et all. Depression and Diabetes Treatment Nonadherence: A Meta-Analysis. Diabetes Care. 2008; 31(12):2398-403.
17. Yaffe K, Lindquist K. Schwartz AV, Vitartas C, Vittinghoff E, Satterfield S, et all. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology. 2014; 77(14):1351-6.
18. Kimy H, Lee KJ. Serum homocysteine levels are correlated with behaviora and psycholosical symptoms of Alzheimer's disease. Neuropsychiatr Dis Treat. 2014;10:1887-96.
19. Alzheimer'sDisease International. World Alzheimer report [Internet]. London: Alzheimer Disease International [update 2009; Citado 2015 Ene 14]. Disponible desde: http://www.alz.co.uk/research/files/worldAlzheimerReport-ExecutiveSummary.pdf
20. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005; 366(9503):2112-7.
21. Taguchi A. Vascular factors in diabetes and Alzheimer's disease. J Alzheimers Dis. 2009; 16(4):859-64.
22. Wang E, Guo X, Shen X, Kream RM, Mantione KJ, Stefano GB. Vascualr dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage. Med Sci Monit Basic Res. 2014; 1(20):118-29.
23. Schrijvers EM, Witteman JC, Sijbrands EJ, Hofman A, Koudstaal PJ, Breteler MM. Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study. Neurology. 2010; 75(22):1982-7.
24. Akomolafe A, Beiser A, Meigs JB, Au R, Green RC, Farrer LA. Diabetes Mellitus and Risk of Developing Alzheimer Disease: Results From the Framingham Study. Arc Neurol. 2006; 63(11):1551-5.
25. Bruce DG, Davis WA, Casey GP, Starkstein SE, Clarnette RM, Foster JK, et al. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia. 2008; 51(2):241-8.
26. Marcuello C, Calle-Pascual AL, Fuentes M, Runkle I, Soriguer F, Goday A, et al. Evaluation of Health-Related Quality of Life according to Carbohydrate Metabolism Status: A Spanish Population-Based Study (Di@bet.es Study). Inte Clin Nephrol [Internet]. 2012 [Citado el 10 de Enero de 2015], Article ID 872305, 6 pages. Disponible desde:
http://dx.doi.org/10.1155/2012/872305
27. Corriere M, Rooparinesingh N, Rastogi Kalyan R. Epidemiology of Diabetes and Diabetes Complications in the Elderly: An Emerging Public Health Burden. Curr Diab Rep. 2013; 13(6):425-8.
28. Mejía-Arango S, Zúñiga-Gil C. Diabetes mellitus as a risk factor for dementia in the Mexican elder population. Rev Neurol. 2011; 53(7):397-405.
29. Katon W, Lyles CR, Parker MM, Karter AJ, Huang ES, Whitmer RA. Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study. Arch Gen Psychiatry. 2012; 69(4):410-7.
30. Biemans E, Hart HE, Rutten GE, Cuellar Renteria VG, Kooijman-Buiting AM, Beulen JW. Cobalamin status and its relation with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin. Acta Diabetol. 2014; 52(2):383-93.
31. Khuwaja AK, Lalani S, Dhanani R, Azam IS, Rafique G. White F. Anxiety and depression among outpatients with type 2 diabetes: A multi-centre study of prevalence and associated factors. Diabatology and metabolic síndrome. 2010; 2:72-6.
32. Tovilla-Zarate C, Juárez-Rojo I, Peralta Y, Jiménez MA, Vázquez S, Bermúdez-Ocaña D, et all. Prevalence of Anxiety and Depression among Out patients with Type 2 Diabetes in the Mexican Population. PLoSOne. 2012; 7(5):36887-90.
33. Sullivan MD, Katon WJ, Lovato LC, Miller ME, Murray AM, Horowitz KR, et al. Association of Depression With Accelerated Cognitive Decline Among Patients With Type 2 Diabetes in the ACCORD-MIND. JAMA Psychiatry. 2013; 70(10):1041-7.
34. Yamazaki Y, Miwa T, Sakurai H, Hanyu H, Iwamoto T, Odawara M. Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients. Endocr J. 2011; 58(2):109-15.
35. Moore EM, Mander AG, Ames D, Kotowicz M, Carne RP, Brodaty H, et all. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care. 2013; 36(10):2981-7.
36. Lee YL, Kang HM, Kim NK, Yang JY, Noh JH, Ko KS, et all. Factors Associated for Mild Cognitive Impairment in Older Korean Adults with Type 2 Diabetes Mellitus. Diabetes Metab J. 2014; 38(2): 150-7.
37. Huang CC, Chung CM, Leu HB, Lin LY, Chiu CC, Hsu CY, et all. Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study. PLoS One. 2014; 9(1):87095-102.
38. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358:2560-72.
39. Gerstein HC, Riddle MC, Kendall DM, Cohen RM, Goland R, Feinglos MN, et al. For the ACCORD Study Group. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J cardiol. 2007; 99:34-43.
40. Obeid R. Metformin causing vitamin B12 deficiency: a guilty verdict without sufficient evidence. Diabetes Care. 2014; 37(2):22-3.
41. Calvo JM, Ramiro JM. Vitamina b12 en pacientes diabeticos tipo 2 en tratamiento con metformina. Endocrinología y Nutrición. 2012; 59(8):487-90.

 

Principio de pgina 

Pie Doc

 

RECURSOS CUIDEN

 

RECURSOS CIBERINDEX

 

FUNDACION INDEX

 

GRUPOS DE INVESTIGACION

 

CUIDEN
CUIDEN citación

REHIC Revistas incluidas
Como incluir documentos
Glosario de documentos periódicos
Glosario de documentos no periódicos
Certificar producción
 

 

Hemeroteca Cantárida
El Rincón del Investigador
Otras BDB
Campus FINDEX
Florence
Pro-AKADEMIA
Instrúye-T

 

¿Quiénes somos?
RICO Red de Centros Colaboradores
Convenios
Casa de Mágina
MINERVA Jóvenes investigadores
Publicaciones
Consultoría

 

INVESCOM Salud Comunitaria
LIC Laboratorio de Investigación Cualitativa
OEBE Observatorio de Enfermería Basada en la Evidencia
GED Investigación bibliométrica y documental
Grupo Aurora Mas de Investigación en Cuidados e Historia
FORESTOMA Living Lab Enfermería en Estomaterapia
CIBERE Consejo Iberoamericano de Editores de Revistas de Enfermería